Clinical Trial Update: Efficacy and Influencing Factors of Secukinumab in Patients With Axial Spondyloarthritis

View source ↗

Summary

A completed clinical trial evaluating the efficacy of secukinumab in axial spondyloarthritis and examining factors that influence treatment outcomes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Axial Spondyloarthritis

Drugs mentioned

• Cosentyx (secukinumab)

Snippet

Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | Conditions: Axial Spondylarthritis (axSpA), Secukinumab | Status: COMPLETED